This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Campus
  1. Article
  2. Source: Campus Sanofi
  3. 31 Oct 2024
3 min

Quality of life and symptom measurement in COPD patients

Author: Sanofi Editorial Team

  
Woman coughing - quality of life COPD

Dupixent (dupilumab) Prescribing Information (GB only)

The SGRQ measures the qualitative impact of COPD1,2

Some domains evaluated by the SGRQ include1,2:

cough icon

Cough

Image of sputum production

Sputum production

Image of breathlessness

Breathlessness

Image of weezing

Wheezing

      

Image of exacerbation

Exacerbations

Image of work activities

Work activities

Daily activities*

Image of medication_impact

Medication use

*Such as walking upstairs or getting dressed.

E-RS:COPD assesses COPD symptoms3,4,b

Some domains evaluated by the E-RS:COPD include3,4:

Image of breathlessness

Breathlessness

Image of sputum production

Cough & Sputum 

Image of Chest congestion

Chest symptoms

Additional Attributes (tired or weak, sleep disturbance, scared or worried)

This is not an exhaustive list of items evaluated by the SGRQ and E-RS:COPD.

a The SGRQ is a 50-item questionnaire designed to measure the qualitative impact of COPD on overall health , daily life, and perceived well-being. Higher scores mean greater disease severity.1,2
b E-RS:COPD is an 11-item patient-reported derivative tool that measures the effect of treatment on respiratory symptom severity in patients with stable COPD . Higher scores mean greater disease severity. 3,4


COPD, chronic obstructive pulmonary disease; E-RS:COPD, Evaluating Respiratory Symptoms in COPD; QoL, quality of life; SGRQ, St George’s Respiratory Questionnaire

References
  1. St Georges' University of London. St. George's Respiratory Questionnaire for COPD patients (SGRQ-C). 2003. Available at https://www.sgul.ac.uk/research/research-operations/research-administration/st-georges-respiratory-questionnaire/docs/SGRQ-C-English-version.pdf. Accessed 23/07/2024.
  2. St. George's University of London. SGRQ Manual March 2022. Available at https://www.sgul.ac.uk/research/research-operations/research-administration/st-georges-respiratory-questionnaire/docs/SGRQ-Manual-March-2022.pdf. Accessed 23/07/2024
  3. Leidy NK, et al. Performance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11:316-25.
  4. Evidera website. EXACT and E-RS:COPD content. Available at https://www.evidera.com/what-we-do/patient-centered-research/coa-instrument-management-services/exact-program/exact-content/ Accessed 23/07/2024.
  5. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2024 report). Available at  https://goldcopd.org/2024-gold-report/ Accessed 23/07/2024

MAT-XU-2402877 (v2.0) Date of Preparation: October 2024